← BOSTON SCIENTIFIC CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 TTM
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net loss (gain) on investments and notes receivable $21.0m $92.0m ($155.0m) $30.0m ($398.0m) ($250.0m) $1.0m $59.0m $79.0m ($139.0m) —
Net Income (Loss) Available to Common Stockholders, Basic $347.0m
$104.0m -70.03%
$1.7b +1506.73%
$4.7b +181.27%
($115.0m) -102.45%
$985.0m +956.52%
$642.0m -34.82%
$1.6b +144.55%
$1.9b +18.03%
$2.9b +56.40%
—
Net Income (Loss) Attributable to Noncontrolling Interest — — — — — — — $1.0m ($8.0m) ($6.0m) —
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $347.0m $104.0m $1.7b $4.7b ($82.0m) $1.0b $698.0m $1.6b $1.8b $2.9b —
Amortization of Intangible Assets $545.0m $565.0m $599.0m $699.0m $789.0m $741.0m $803.0m $828.0m $856.0m $897.0m —
Depreciation $270.0m $279.0m $296.0m $311.0m $333.0m $352.0m $333.0m $367.0m $412.0m $471.0m $483.0m
Depreciation, Depletion and Amortization $815.0m $844.0m $894.0m $1.0b $1.1b $1.1b $1.1b $1.2b $1.3b $1.4b $1.4b
Inventory step-up amortization $22.0m $10.0m $6.0m $46.0m $58.0m $34.0m $32.0m $6.0m $51.0m $132.0m —
Deferred Income Tax Expense (Benefit) ($343.0m) $244.0m ($162.0m) ($4.3b) ($85.0m) ($142.0m) ($7.0m) $73.0m ($90.0m) ($12.0m) ($287.0m)
Proceeds from issuances of shares of common stock pursuant to employee stock compensation and purchase plans — — $101.0m $123.0m $111.0m $110.0m $136.0m $182.0m $230.0m $282.0m —
Share-based Payment Arrangement, Noncash Expense $116.0m $127.0m $140.0m $157.0m $170.0m $194.0m $220.0m $233.0m $266.0m $299.0m $320.0m
Stock-based compensation expense $116.0m $127.0m $140.0m $157.0m $170.0m $194.0m $220.0m $233.0m $266.0m $299.0m $320.0m
Fixed asset and right-of-use asset impairment — — — — — — — $27.0m $72.0m $124.0m —
Goodwill and other intangible asset impairment charges $11.0m $4.0m $35.0m $105.0m $533.0m $370.0m $132.0m $58.0m $386.0m $46.0m —
Goodwill, Impairment Loss $0 — — — $73.0m $0 $0 — — — $124.0m
Impairment of Intangible Assets (Excluding Goodwill) $11.0m $4.0m $35.0m $105.0m $460.0m $370.0m $132.0m $58.0m $386.0m $46.0m —
Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) $11.0m $4.0m $35.0m $105.0m $533.0m $370.0m $132.0m $58.0m $386.0m $46.0m —
Nonoperating Income (Expense) ($270.0m) ($353.0m) ($85.0m) ($831.0m) $1.0m ($123.0m) ($508.0m) ($358.0m) — — —
Other Nonoperating Income (Expense) ($37.0m) ($124.0m) $156.0m ($358.0m) $362.0m $218.0m ($38.0m) ($93.0m) ($321.0m) ($228.0m) —
Changes in operating assets and liabilities:
Increase (Decrease) in Accounts Receivable $216.0m $30.0m $110.0m $130.0m ($335.0m) $279.0m $220.0m $238.0m $351.0m $269.0m ($293.0m)
Trade accounts receivable ($216.0m) ($30.0m) ($110.0m) ($130.0m) $335.0m ($279.0m) ($220.0m) ($238.0m) ($351.0m) ($269.0m) —
Increase (Decrease) in Inventories ($40.0m) $107.0m $83.0m $290.0m $65.0m $346.0m $321.0m $660.0m $228.0m $188.0m ($454.0m)
Inventories $40.0m ($107.0m) ($83.0m) ($290.0m) ($65.0m) ($346.0m) ($321.0m) ($660.0m) ($228.0m) ($188.0m) ($454.0m)
Accounts payable, accrued expenses and other liabilities $553.0m $195.0m ($631.0m) $111.0m $88.0m $408.0m ($255.0m) $118.0m $243.0m $296.0m $172.0m
Other assets ($253.0m) ($20.0m) ($172.0m) $45.0m ($200.0m) ($134.0m) ($209.0m) $10.0m ($126.0m) ($85.0m) —
Restricted cash and restricted cash equivalents included in Other current assets $269.0m $803.0m $655.0m $346.0m — $188.0m $149.0m $130.0m $111.0m $80.0m —
Net Cash Provided by (Used in) Operating Activities $972.0m
$1.4b +46.71%
$310.0m -78.26%
$1.8b +492.26%
$1.5b -17.86%
$1.9b +24.01%
$1.5b -18.40%
$2.5b +64.02%
$3.4b +37.24%
$4.5b +31.99%
$4.5b -0.15%
Cash flows from investing activities:
Gain (Loss) on Disposition of Property Plant Equipment $11.0m — — — — — — — — — ($94.0m)
Payments to Acquire Property, Plant, and Equipment $376.0m $319.0m $316.0m $461.0m $376.0m $554.0m $588.0m $711.0m $790.0m $876.0m ($2.7b)
Gain (Loss) on Investments ($21.0m) ($92.0m) $155.0m ($30.0m) $398.0m $250.0m ($1.0m) ($59.0m) ($79.0m) $139.0m ($94.0m)
Payments for investments and acquisitions of certain technologies ($132.0m) ($131.0m) ($172.0m) ($149.0m) ($146.0m) $279.0m ($24.0m) ($89.0m) ($280.0m) ($254.0m) —
Payments to Acquire Investments $132.0m $131.0m $172.0m $149.0m $146.0m — — — — — —
Unrealized Gain (Loss) on Investments $21.0m $92.0m ($155.0m) $30.0m $363.0m ($178.0m) $178.0m $59.0m $79.0m ($139.0m) —
Payments for acquisitions of businesses, net of cash acquired ($408.0m) ($560.0m) ($1.4b) ($4.4b) ($3.0m) ($2.3b) ($1.5b) ($1.8b) ($4.6b) ($1.6b) —
Payments to Acquire Businesses, Net of Cash Acquired $408.0m $560.0m $1.4b $4.4b $3.0m $2.3b $1.5b $1.8b $4.6b $1.6b ($1.1b)
Payments for (Proceeds from) Other Investing Activities $0 — — — ($87.0m) ($82.0m) ($70.0m) ($30.0m) ($20.0m) ($84.0m) —
Cash provided by (used for) investing activities ($887.0m) ($1.0b) ($1.9b) ($5.0b) ($411.0m) ($1.6b) ($2.0b) ($2.6b) ($5.7b) ($2.6b) —
Net Cash Provided by (Used in) Investing Activities ($887.0m) ($1.0b) ($1.9b) ($5.0b) ($411.0m) ($1.6b) ($2.0b) ($2.6b) ($5.7b) ($2.6b) ($3.6b)
Cash flows from financing activities:
Gain (Loss) on Extinguishment of Debt — — — $86.0m — — — $0 $0 — —
Net increase (decrease) in commercial paper $0 $1.2b $21.0m ($575.0m) ($714.0m) $0 ($1.0m) ($4.0m) $187.0m ($196.0m) —
Payments on short-term borrowings — $0 $0 ($1.0b) ($3.0b) $0 ($250.0m) $0 ($504.0m) ($1.6b) —
Proceeds from long-term borrowings, net of debt issuance costs $0 $0 $987.0m $7.2b $1.7b $0 $3.3b $0 $2.1b $1.6b —
Repayments of Long-term Debt $250.0m $1.0b $602.0m $3.6b — — — — — — ($216.0m)
Payments for Repurchase of Common Stock $0 — — — $535.0m $0 $0 — — — —
Proceeds from Issuance of Common Stock $111.0m $85.0m $101.0m $123.0m $975.0m $0 $0 $182.0m $230.0m $282.0m $0
Dividends paid — — — — $28.0m $55.0m $55.0m $28.0m $0 — $0
Proceeds from (Payments for) Other Financing Activities — — — — — — — — — $7.0m —
Cash provided by (used for) financing activities ($206.0m)
$110.0m +153.40%
$1.4b +1201.82%
$3.0b +107.61%
$293.0m -90.14%
($95.0m) -132.42%
($548.0m) -476.84%
$5.0m +100.91%
$1.8b +36180.00%
($395.0m) -121.78%
—
Net Cash Provided by (Used in) Financing Activities ($206.0m)
$110.0m +153.40%
$1.4b +1201.82%
$3.0b +107.61%
$293.0m -90.14%
($95.0m) -132.42%
($548.0m) -476.84%
$5.0m +100.91%
$1.8b +36180.00%
($395.0m) -121.78%
($957.0m) -142.28%
Net increase (decrease) in cash, cash equivalents, restricted cash and restricted cash equivalents $87.0m $530.0m ($188.0m) ($222.0m) $1.4b $173.0m ($1.0b) ($70.0m) ($450.0m) $1.5b —
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $87.0m $530.0m ($188.0m) ($222.0m) $1.4b $173.0m ($1.0b) ($70.0m) ($450.0m) $1.5b $751.0m
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period $400.0m $487.0m $829.0m $607.0m $2.0b $2.2b $1.1b $1.1b $606.0m $2.1b $751.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $87.0m $530.0m $829.0m $607.0m $2.0b $2.2b $1.1b $1.1b $606.0m $2.1b $751.0m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($2.0m) $4.0m ($8.0m) $10.0m ($2.0m) ($6.0m) ($9.0m) ($4.0m) ($11.0m) $42.0m $2.0m
Restricted cash equivalents included in Other long-term assets $22.0m $26.0m $27.0m $43.0m — $55.0m $48.0m $60.0m $80.0m $103.0m —
Effect of foreign exchange rates on cash ($2.0m) $4.0m ($8.0m) $10.0m ($2.0m) ($6.0m) ($9.0m) ($4.0m) ($11.0m) $42.0m —
Additional Supplementary Disclosures
Additional Supplementary Disclosures
Additional Financial Items
Cash and cash equivalents $196.0m $188.0m $146.0m $217.0m — $1.9b $928.0m $865.0m $414.0m $2.0b $741.0m
Cash used to net share settle employee equity awards ($62.0m) ($65.0m) ($56.0m) ($65.0m) ($59.0m) ($50.0m) ($53.0m) ($56.0m) ($87.0m) ($131.0m) —
Contingent consideration net expense (benefit) $29.0m ($80.0m) ($21.0m) ($35.0m) ($100.0m) ($136.0m) $35.0m $58.0m ($5.0m) $18.0m —
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $0 — — $8.0m $0 $78.0m ($22.0m) $0 $0 — —
Fair value of contingent consideration recorded in purchase accounting $50.0m $94.0m $248.0m $127.0m $0 $440.0m $0 $273.0m $29.0m $258.0m —
Foreign Currency Transaction Gain (Loss), before Tax ($13.0m) — — — — — — — — — —
Gain (Loss) on Disposition of Business — — — — — $78.0m ($22.0m) $0 $0 — —
Goodwill $6.7b $7.0b $7.9b $10.2b $10.0b $12.0b $12.9b $14.4b $17.1b $18.3b $124.0m
Income Tax Expense (Benefit) ($170.0m) $828.0m ($249.0m) ($4.0b) $2.0m $36.0m $443.0m $393.0m $436.0m $493.0m —
Income Taxes Paid, Net $94.0m $42.0m $1.0b $242.0m $207.0m $302.0m $662.0m $512.0m $656.0m $561.0m —
Interest Paid, Excluding Capitalized Interest, Operating Activities $233.0m $235.0m $262.0m $449.0m $359.0m $338.0m $450.0m $259.0m $250.0m $319.0m —
Noncash transactions related to finance lease obligations — — — — — — — $0 $122.0m $205.0m —
Operating Expenses $5.5b $5.2b $5.5b $6.1b $6.5b $7.0b $7.1b $7.6b $8.9b $10.2b —
Other, net ($12.0m) $27.0m ($3.0m) $63.0m $213.0m $51.0m $125.0m $73.0m $74.0m $7.0m —
Payment of contingent consideration previously established in purchase accounting — — ($19.0m) ($66.0m) ($49.0m) ($15.0m) ($335.0m) ($39.0m) ($131.0m) ($62.0m) —
Payments for finance leases — — — — — — $0 $0 ($25.0m) ($258.0m) —
Supplemental disclosure of cash flow information:

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.